In 2024, the total value of assets held by ToolGen amounted to around 75.48 billion South Korean won. This represents a decrease compared to the previous year. ToolGen is a South Korean biotech company based on CRISPR genome editing technology.
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
I think of Statista as Google for researchers. Statista provides you with the information you search for right away.
Dr. Horst Stipp
EVP, Research & Innovation, Advertising Research Foundation
Global overview
Research & development
R&D country comparison
Products
Funding/M&A/IPOs
Focus: U.S. companies
* For commercial use only
Basic Account
Starter Account
The statistic on this page is a Premium Statistic and is included in this account.
Professional Account
1 All prices do not include sales tax. The account requires an annual contract and will renew after one year to the regular list price.
